The short version

From the latest prices and each company's SEC filings. Who's ahead on each measure, not which to buy.

  • Omega Healthcare Investors is the larger company, worth $14.1B, about 3.0 times Sabra Healthcare REIT.
  • Sabra Healthcare REIT grew revenue faster over the last year (+63.1% vs -95.0%).
  • On earnings, Omega Healthcare Investors is the cheaper stock (21.8x vs 30.0x).

Side by side

The stronger figure is shaded where higher (or, for valuation multiples, lower) reads as better. How the implied growth works.

MeasureOHISBRA
Market cap$14.1B$4.8B
Share price$44.41$18.96
Revenue (last fiscal year)$1.2B$357M
Free cash flow (last fiscal year)$798M—
Revenue growth, last year-95.0%+63.1%
Revenue growth per year, last 5 fiscal years+2.9%+23.1%
Operating margin——
Net margin131.8%14.7%
Return on equity15.9%2.4%
P/E (trailing)21.8x30.0x
Price / free cash flow16.0x13.7x
EV / EBITDA12.0x18.8x
FCF growth the price implies3.3%—
Dividend yield6.0%6.4%
Debt / equity0.81x1.00x
Fundamental gradeBD
Superinvestors holding it02
Insider purchases, last 12 months20

Results from SEC filings

Revenue and free cash flow by fiscal year, from each company's 10-K filings.

Omega Healthcare Investors

YearRevenueFree cash flowOp. margin
2021$1.1B$677M—
2022$878M$579M—
2023$950M$580M—
2024$1.1B$712M—
2025$1.2B$798M—

Sabra Healthcare REIT

YearRevenueFree cash flowOp. margin
2021$156M——
2022$187M——
2023$236M——
2024$285M——
2025$357M——
Compare them in fullFifteen years of statements, quarterly results, DCF and IRR models, and any number of peers side by side.
Open OHI in Investingly

Questions

Which is bigger, Omega Healthcare Investors or Sabra Healthcare REIT?

Omega Healthcare Investors (OHI), at $14.1B against $4.8B.

Is OHI or SBRA cheaper?

By trailing P/E, Omega Healthcare Investors (21.8x) is cheaper than Sabra Healthcare REIT (30.0x). A lower multiple can also mean the market expects less growth.

Which grows faster, OHI or SBRA?

Sabra Healthcare REIT: revenue grew +63.1% over the last year, against -95.0%.

Prices and ratios as of the last daily update; statements from SEC filings. Information only, not investment advice.